Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter R Donald

Showing results (41-50 of 81) with videos related to

Pageof 9
Sort By:
British Journal of Clinical Pharmacology|May 30, 2020
The pharmacokinetics of para-aminosalicylic acid and its relationship to efficacy and intoleranceAhmed A Abulfathi, Peter R Donald, Kim Adams, et al.
Journal of the Pediatric Infectious Diseases Society|September 26, 2015
Successful Treatment of a Child With Extensively Drug-Resistant Tuberculous MeningitisNeele Alsleben, Anthony J Garcia-Prats, Anneke C Hesseling, et al.
American Journal of Respiratory and Critical Care Medicine|February 18, 2006
Childhood pulmonary tuberculosis: old wisdom and new challengesBen J Marais, Robert P Gie, H Simon Schaaf, et al.
The Pediatric Infectious Disease Journal|August 12, 2005
Recurrent culture-confirmed tuberculosis in human immunodeficiency virus-infected childrenH Simon Schaaf, Sara Krook, Dete W Hollemans, et al.
Acta Paediatrica (Oslo, Norway : 1992)|July 11, 2006
Childhood drug-resistant tuberculosis in the Western Cape Province of South AfricaH Simon Schaaf, Ben J Marais, Anneke C Hesseling, et al.
Journal of Clinical Pharmacology|November 5, 2019
Pharmacokinetics of Para-Aminosalicylic Acid and Its 2 Major Metabolites: A Potential Relationship to the Development of Gastrointestinal IntoleranceKim T Adams, Peter R Donald, Ahmed A Abulfathi, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|June 28, 2019
Evolution of rifampicin treatment for tuberculosisMelanie Grobbelaar, Gail E Louw, Samantha L Sampson, et al.
Plos Medicine|August 22, 2008
Ensuring the involvement of children in the evaluation of new tuberculosis treatment regimensWilliam J Burman, Mark F Cotton, Diana M Gibb, et al.
Journal of Paediatrics and Child Health|September 1, 2020
Extensive pulmonary and extrapulmonary tuberculosis in a child presenting with a chest wall abscess: The value of different modes of imagingPierre Goussard, Savvas Andronikou, Lunga Mfingwana, et al.
Tuberculosis (Edinburgh, Scotland)|December 3, 2014
Pre-treatment mycobacterial sputum load influences individual on-treatment measurementsAndreas H Diacon, Lize van der Merwe, Anne-Marie Demers, et al.
Pageof 9

Showing results (41-50 of 81) with videos related to

Sort By:
Pageof 9
British Journal of Clinical Pharmacology|May 30, 2020
The pharmacokinetics of para-aminosalicylic acid and its relationship to efficacy and intoleranceAhmed A Abulfathi, Peter R Donald, Kim Adams, et al.
Journal of the Pediatric Infectious Diseases Society|September 26, 2015
Successful Treatment of a Child With Extensively Drug-Resistant Tuberculous MeningitisNeele Alsleben, Anthony J Garcia-Prats, Anneke C Hesseling, et al.
American Journal of Respiratory and Critical Care Medicine|February 18, 2006
Childhood pulmonary tuberculosis: old wisdom and new challengesBen J Marais, Robert P Gie, H Simon Schaaf, et al.
The Pediatric Infectious Disease Journal|August 12, 2005
Recurrent culture-confirmed tuberculosis in human immunodeficiency virus-infected childrenH Simon Schaaf, Sara Krook, Dete W Hollemans, et al.
Acta Paediatrica (Oslo, Norway : 1992)|July 11, 2006
Childhood drug-resistant tuberculosis in the Western Cape Province of South AfricaH Simon Schaaf, Ben J Marais, Anneke C Hesseling, et al.
Journal of Clinical Pharmacology|November 5, 2019
Pharmacokinetics of Para-Aminosalicylic Acid and Its 2 Major Metabolites: A Potential Relationship to the Development of Gastrointestinal IntoleranceKim T Adams, Peter R Donald, Ahmed A Abulfathi, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|June 28, 2019
Evolution of rifampicin treatment for tuberculosisMelanie Grobbelaar, Gail E Louw, Samantha L Sampson, et al.
Plos Medicine|August 22, 2008
Ensuring the involvement of children in the evaluation of new tuberculosis treatment regimensWilliam J Burman, Mark F Cotton, Diana M Gibb, et al.
Journal of Paediatrics and Child Health|September 1, 2020
Extensive pulmonary and extrapulmonary tuberculosis in a child presenting with a chest wall abscess: The value of different modes of imagingPierre Goussard, Savvas Andronikou, Lunga Mfingwana, et al.
Tuberculosis (Edinburgh, Scotland)|December 3, 2014
Pre-treatment mycobacterial sputum load influences individual on-treatment measurementsAndreas H Diacon, Lize van der Merwe, Anne-Marie Demers, et al.
Pageof 9